These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9112423)

  • 1. Hyperinsulinemia potentiates activation of p21Ras by growth factors.
    Leitner JW; Kline T; Carel K; Goalstone M; Draznin B
    Endocrinology; 1997 May; 138(5):2211-4. PubMed ID: 9112423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GTP loading of farnesylated p21Ras by insulin at the plasma membrane.
    Goalstone M; Leitner JW; Draznin B
    Biochem Biophys Res Commun; 1997 Oct; 239(1):42-5. PubMed ID: 9345266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals.
    Goalstone ML; Wall K; Leitner JW; Kurowski T; Ruderman N; Pan SJ; Ivy JL; Moller DE; Draznin B
    Diabetologia; 1999 Mar; 42(3):310-6. PubMed ID: 10096783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin stimulates mitogen-activated protein kinase by a Ras-independent pathway in 3T3-L1 adipocytes.
    Carel K; Kummer JL; Schubert C; Leitner W; Heidenreich KA; Draznin B
    J Biol Chem; 1996 Nov; 271(48):30625-30. PubMed ID: 8940037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway.
    Goalstone M; Carel K; Leitner JW; Draznin B
    Endocrinology; 1997 Dec; 138(12):5119-24. PubMed ID: 9389491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects.
    Solomon CS; Goalstone ML
    Biochem Biophys Res Commun; 2001 Jul; 285(2):161-6. PubMed ID: 11444820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor.
    Goalstone ML; Leitner JW; Wall K; Dolgonos L; Rother KI; Accili D; Draznin B
    J Biol Chem; 1998 Sep; 273(37):23892-6. PubMed ID: 9727002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that p21ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons.
    Robinson LJ; Leitner W; Draznin B; Heidenreich KA
    Endocrinology; 1994 Dec; 135(6):2568-73. PubMed ID: 7988444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells.
    Goalstone ML; Natarajan R; Standley PR; Walsh MF; Leitner JW; Carel K; Scott S; Nadler J; Sowers JR; Draznin B
    Endocrinology; 1998 Oct; 139(10):4067-72. PubMed ID: 9751484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes.
    Goalstone ML; Draznin B
    J Biol Chem; 1996 Nov; 271(44):27585-9. PubMed ID: 8910345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.
    Draznin B; Miles P; Kruszynska Y; Olefsky J; Friedman J; Golovchenko I; Stjernholm R; Wall K; Reitman M; Accili D; Cooksey R; McClain D; Goalstone M
    Endocrinology; 2000 Apr; 141(4):1310-6. PubMed ID: 10746633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.
    Kothapalli R; Guthrie N; Chambers AF; Carroll KK
    Lipids; 1993 Nov; 28(11):969-73. PubMed ID: 8277827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin on farnesyltransferase gene transcription and mRNA stability.
    Goalstone ML; Draznin B
    Biochem Biophys Res Commun; 1999 Jan; 254(1):243-7. PubMed ID: 9920764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent mechanisms for homologous desensitization of p21ras by insulin and growth factors.
    Klarlund JK; Cherniack AD; Czech MP
    J Biol Chem; 1995 Oct; 270(40):23421-8. PubMed ID: 7559502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of farnesyltransferase and Ras processing peptidase.
    Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal-growth-factor receptors generate Ras.GTP more efficiently than insulin receptors.
    Osterop AP; Medema RH; vd Zon GC; Bos JL; Möller W; Maassen JA
    Eur J Biochem; 1993 Mar; 212(2):477-82. PubMed ID: 8444185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues.
    Stephens E; Thureen PJ; Goalstone ML; Anderson MS; Leitner JW; Hay WW; Draznin B
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E217-23. PubMed ID: 11440896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant negative alpha-subunit of farnesyl- and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes.
    Solomon CS; Leitner JW; Goalstone ML
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):40-7. PubMed ID: 12532152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant negative alpha-subunit of FTase inhibits effects of insulin and IGF-I in MCF-7 cells.
    Solomon CS; Goalstone ML
    Biochem Biophys Res Commun; 2002 Mar; 291(3):458-65. PubMed ID: 11855811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.